Literature DB >> 9008797

Functional analysis of antibody responses of feedlot cattle to bovine respiratory syncytial virus following vaccination with mixed vaccines.

K West1, J Ellis.   

Abstract

The antibody response of cattle to bovine respiratory syncytial virus (BRSV) immunization was investigated using 4 different commercially available mixed vaccines. Forty, 5-6 month old, beef calves, randomly assigned to groups of 10, were vaccinated on day 0 and 21 with 1 of 3 inactivated vaccines, (3 groups), or a modified live virus (MLV) vaccine. BRSV-specific antibody responses were measured prior to vaccination and on day 35 by using an enzyme linked immunosorbent assay (ELISA), virus neutralization assay (VN), a fusion inhibition assay (FI); and responses were also measured for their ability to facilitate antibody dependent, complement mediated cytotoxicity (ADCMC) of BRSV infected cells. Sera from day 35 were, in addition, analyzed by use of an IgG1, IgG2 isotype specific ELISA. All vaccines induced significant increases in BRSV specific IgG antibody as measured by ELISA, but only one inactivated and the MLV vaccine induced significant increases in VN titers. Fusion inhibiting antibody titers were low or undetected in calves vaccinated with the inactivated vaccines. Vaccination with modified live virus induced significantly higher titers of fusion inhibiting antibodies, which are considered to be most highly correlated with protection. The VN to ELISA and FI to ELISA ratio of the calves that received MLV vaccine were significantly greater than the calves receiving the 3 inactivated vaccines. Vaccination with MLV induced the highest IgG2/IgG1 ratio. This difference was small, and only significant relative to 2 of the inactivated vaccine groups, which were not significantly different from each other. The higher proportion of IgG2 isotype in the MLV sera was not associated with lower ADCMC, a function not attributed to this isotype. The VN and FI titers, but not the ELISA value of the sera, were most predictive of ADCMC. The inactivation processes apparently alter epitopes and affect the induction of functional antibodies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9008797      PMCID: PMC1189365     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  35 in total

1.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.

Authors:  M B Hansen; S E Nielsen; K Berg
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

2.  Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus.

Authors:  Y W Tang; B S Graham
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

3.  Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells.

Authors:  L J Anderson; C Tsou; C Potter; H L Keyserling; T F Smith; G Ananaba; C R Bangham
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

4.  Regulation of the interaction between Th1 and Th2 T cell clones to provide help for antibody production in vivo.

Authors:  L V Rizzo; R H DeKruyff; D T Umetsu; R R Caspi
Journal:  Eur J Immunol       Date:  1995-03       Impact factor: 5.532

5.  The role of passive immunity in bovine respiratory syncytial virus-infected calves.

Authors:  E B Belknap; J C Baker; J S Patterson; R D Walker; D M Haines; E G Clark
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

6.  Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum.

Authors:  B S Graham; T H Davis; Y W Tang; W C Gruber
Journal:  Pediatr Res       Date:  1993-08       Impact factor: 3.756

7.  Increased bronchoalveolar IgG2/IgG1 ratio is a marker for human lung allograft rejection.

Authors:  D S Wilkes; K M Heidler; M Niemeier; G R Schwenk; P N Mathur; W M Breite; O W Cummings; J C Weissler
Journal:  J Investig Med       Date:  1994-12       Impact factor: 2.895

8.  Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.

Authors:  B S Graham; G S Henderson; Y W Tang; X Lu; K M Neuzil; D G Colley
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

9.  Bovine respiratory syncytial virus-specific immune responses in cattle following immunization with modified-live and inactivated vaccines. Analysis of the specificity and activity of serum antibodies.

Authors:  J A Ellis; H Russell; J Cavender; T R Haven
Journal:  Vet Immunol Immunopathol       Date:  1992-10       Impact factor: 2.046

10.  Clinical and immunologic response of cattle to administration of a vaccine containing modified-live bovine respiratory syncytial virus.

Authors:  J A Ellis; W C Davis; L Talens; D L Pratt
Journal:  J Am Vet Med Assoc       Date:  1990-02-15       Impact factor: 1.936

View more
  11 in total

1.  Comparative efficacy of modified-live and inactivated vaccines in boosting responses to bovine respiratory syncytial virus following neonatal mucosal priming of beef calves.

Authors:  John Ellis; Sheryl Gow; Adam Berenik; Stacey Lacoste; Nathan Erickson
Journal:  Can Vet J       Date:  2018-12       Impact factor: 1.008

2.  Efficacy of a saponin-adjuvanted inactivated respiratory syncytial virus vaccine in calves.

Authors:  John A Ellis; Keith H West; Cheryl Waldner; Carrie Rhodes
Journal:  Can Vet J       Date:  2005-02       Impact factor: 1.008

3.  Inhibition of priming for bovine respiratory syncytial virus-specific protective immune responses following parenteral vaccination of passively immune calves.

Authors:  John Ellis; Sheryl Gow; Michael Bolton; William Burdett; Scott Nordstrom
Journal:  Can Vet J       Date:  2014-12       Impact factor: 1.008

4.  Bovine respiratory syncytial virus-specific IgG-1 in nasal secretions of colostrum-fed neonatal calves.

Authors:  John A Ellis; Manuel F Chamorro; Stacey Lacoste; Sheryl P Gow; Deborah M Haines
Journal:  Can Vet J       Date:  2018-05       Impact factor: 1.008

5.  Utilization of complement-dependent cytotoxicity to measure low levels of antibodies: application to nonstructural protein 1 in a model of Japanese encephalitis virus.

Authors:  Eiji Konishi; Yoko Kitai; Takashi Kondo
Journal:  Clin Vaccine Immunol       Date:  2007-11-21

6.  Comparison of humoral immune responses in dairy heifers vaccinated with 3 different commercial vaccines against bovine viral diarrhea virus and bovine herpesvirus-1.

Authors:  Luc DesCôteaux; Dominique Cécyre; Johanne Elsener; Guy Beauchamp
Journal:  Can Vet J       Date:  2003-10       Impact factor: 1.008

7.  Infection of calves with in-vivo passaged bovine parainfluenza-3 virus, alone or in combination with bovine respiratory syncytial virus and bovine coronavirus.

Authors:  John Ellis; Nathan Erickson; Sheryl Gow; Keith West; Stacey Lacoste; Dale Godson
Journal:  Can J Vet Res       Date:  2020-07       Impact factor: 1.310

Review 8.  DNA vaccines in veterinary use.

Authors:  Laurel Redding; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2009-09       Impact factor: 5.217

9.  A single vaccination with an inactivated bovine respiratory syncytial virus vaccine primes the cellular immune response in calves with maternal antibody.

Authors:  Mirjam T W van der Sluijs; Eva M Kuhn; Birgit Makoschey
Journal:  BMC Vet Res       Date:  2010-01-11       Impact factor: 2.741

Review 10.  Review on bovine respiratory syncytial virus and bovine parainfluenza - usual suspects in bovine respiratory disease - a narrative review.

Authors:  Birgit Makoschey; Anna Catharina Berge
Journal:  BMC Vet Res       Date:  2021-07-31       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.